Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine

Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine

Systemic lupus erythematosus (SLE) preferentially affects women of childbearing age. Miscarriages or fetal death, intrauterine growth restriction (IUGR), preterm delivery, preeclampsia and disease flares complicate pregnancy in SLE patients. Treatment is challenging due to the need to prevent diseas...

Full description

Bibliographic Details
Main Authors: Valentina Canti, Margherita Scarrone, Rebecca De Lorenzo, Giuseppe A. Ramirez, Roberta Erra, Sara Bordoli, Sara Cella, Elena Schmit, Susanna Rosa, Maria T. Castiglioni, Patrizia Rovere-Querini
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Immunological Medicine
Subjects:
systemic lupus erythematosus
hydroxychloroquine
pregnancy
adverse pregnancy outcomes
systemic autoimmune diseases
Online Access:http://dx.doi.org/10.1080/25785826.2020.1868652

Internet

http://dx.doi.org/10.1080/25785826.2020.1868652

Similar Items